Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Iovance Biotherapeutics (IOVA) Return on Capital Employed (2016 - 2025)

Iovance Biotherapeutics (IOVA) has disclosed Return on Capital Employed for 9 consecutive years, with 0.11% as the latest value for Q4 2025.

  • On a quarterly basis, Return on Capital Employed changed N/A to 0.11% in Q4 2025 year-over-year; TTM through Dec 2025 was 0.11%, a N/A change, with the full-year FY2025 number at 0.11%, up 44.0% from a year prior.
  • Return on Capital Employed was 0.11% for Q4 2025 at Iovance Biotherapeutics, up from 0.53% in the prior quarter.
  • In the past five years, Return on Capital Employed ranged from a high of 0.11% in Q4 2025 to a low of 0.66% in Q4 2023.
  • A 3-year average of 0.49% and a median of 0.51% in 2025 define the central range for Return on Capital Employed.
  • Peak YoY movement for Return on Capital Employed: decreased -15bps in 2024, then rose 15bps in 2025.
  • Iovance Biotherapeutics' Return on Capital Employed stood at 0.66% in 2023, then increased by 3bps to 0.64% in 2024, then soared by 83bps to 0.11% in 2025.
  • Per Business Quant, the three most recent readings for IOVA's Return on Capital Employed are 0.11% (Q4 2025), 0.53% (Q3 2025), and 0.51% (Q2 2025).